Gregory D. Gorgas
CIK 1526251 · Pres, CEO, CFO, Treas & Secr · last filed 2026-02-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ARTLW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 210
LA JOLLA, CA 92037
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARTL | Pres, CEO, CFO, Treas & Secr | — | $3.26 | — | $0 | 4 | 2026-02-02 |
| ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Pres, CEO, CFO, Treas & Sec | 273,076 | $0.01 | $1.5K | $61.2K | 16 | 2024-03-01 |
| MSTX | Senior VP, Commercial | — | $18.26 | — | $0 | 5 | 2016-01-06 |
| Savara Inc (ANX) Delisted | Senior VP, Commercial | — | — | — | $0 | 3 | 2013-01-03 |
Recent Filings · Page 2 of 3
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-20 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Buy (P) | +8,500 | $9.8K | EDGAR |
| 2021-03-09 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-17 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-19 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Buy (P) | +4,200 | $5.1K | EDGAR |
| 2020-05-04 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Buy (P) | +4,167 | $5.0K | EDGAR |
| 2019-11-05 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Buy (P) | +2,400 | $5.3K | EDGAR |
| 2019-11-01 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Buy (P) | +7,600 | $15.8K | EDGAR |
| 2019-10-17 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Buy (P) | +2,600 | $5.3K | EDGAR |
| 2019-10-11 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Buy (P) | +2,700 | $5.3K | EDGAR |
| 2019-08-30 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.